25
Participants
Start Date
July 31, 2011
Primary Completion Date
March 31, 2013
Study Completion Date
December 31, 2013
Solution B (balance PD solution)
balance 1.5% glucose, solution for peritoneal dialysis; balance 2.3% glucose, solution for peritoneal dialysis; balance 4.25% glucose, solution for peritoneal dialysis, each with 1.25 mmol/l or 1.75 mmol/l calcium
Solution A (conventional PD solution)
Solutions for peritoneal dialysis: CAPD 2 (1.5% glucose, 1.75mmmol/l calcium), CAPD 3 (4.25 % glucose, 1.75mmmol/l calcium), CAPD 4 (2.3% glucose, 1.75mmmol/l calcium), CAPD 17 (1.5% glucose, 1.25mmmol/l calcium), CAPD 18 (4.25% glucose, 1.25mmmol/l calcium) and CAPD 19 (2.3% glucose, 1.25mmmol/l calcium)
Centrum Dializ Fresenius Nephrocare, Gdansk
Uniwersytecki Szpital Kliniczny nr 1, Lodz
Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie, Lublin
Complejo hospitalario universitario de Albacete, Albacete
Fundación Hospital Alcorcón, Madrid
Hospital Universitario Puerta de Hierro, Madrid
Hospital Universitario Ramón y Cajal, Madrid
Fresenius Medical Care Deutschland GmbH
INDUSTRY